Literature DB >> 10233427

Genotypic, immunophenotypic and clinical features of Thai patients with paroxysmal nocturnal haemoglobinuria.

P Pramoonjago1, K Pakdeesuwan, U Siripanyaphinyo, S Chinprasertsuk, T Kinoshita, W Wanachiwanawin.   

Abstract

Paroxysmal nocturnal haemoglobinuria (PNH) is an acquired haematological disorder characterized by complement-mediated haemolytic anaemia caused by deficiency of glycosylphosphatidylinositol (GPI) anchored proteins. Somatic mutation of an X-linked gene, PIG-A, is responsible for the defect in biosynthesis of GPI-anchor. It appears that frequency of PNH differs geographically, and seems to be more frequent in some Asian countries, such as Thailand and China. We studied a group of 34 Thai patients with PNH to see whether the somatic mutations in PIG-A, extent of deficiency of GPI-anchored proteins (complete or partial) and complication with aplastic anaemia among Thai patients are different from those in other regions. We determined 37 PIG-A mutations in 33 patients (10 base substitutions, 14 single-base deletions, five multiple-base deletions, three single-base insertions, two multiple base insertions and three others) which were found to be similar to those found in European, American and Japanese patients. Most patients had cells with a complete deficiency of CD59 (type III cells), whereas 19% and 33% of the patients with reliable data for CD59 expression had partially deficient granulocytes and erythrocytes (type II cells), respectively. Most mutations resulted in a complete loss of function of PIG-A in accordance with the prevalent PNH III phenotype. 19 patients (51%) had aplastic anaemia; their PIG-A mutations were not different from those without pre-existing aplastic anaemia. These characteristics of Thai patients are similar to patients from other regions. There was some negative correlation between mean basal Hb concentration and percentage of CD59-negative granulocytes (r = -0. 374; P = 0.0476). In addition, patients with severe anaemia (basal Hb <7 g/dl) had a significantly higher percentage of affected granulocytes than those with mild anaemia (88.5 +/- 9.4 v 64.9 +/- 25.9; P = 0.01). The data suggest that the severity of anaemia in PNH depends partly on the size of the PNH clone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233427

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  Mutation analysis of the PIG-A gene in Korean patients with paroxysmal nocturnal haemoglobinuria.

Authors:  J H Yoon; H I Cho; S S Park; Y H Chang; B K Kim
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

2.  Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.

Authors:  K Pakdeesuwan; W Muangsup; Y U Pratya; S Issaragrisil; W Wanachiwanawin
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

3.  Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.

Authors:  Antonio M Risitano; Bruno Rotoli
Journal:  Biologics       Date:  2008-06

Review 4.  Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations.

Authors:  Fatimah Al-Ani; Ian Chin-Yee; Alejandro Lazo-Langner
Journal:  Ther Clin Risk Manag       Date:  2016-08-01       Impact factor: 2.423

5.  Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab.

Authors:  Austin G Kulasekararaj; Antonio M Risitano; Jaroslaw P Maciejewski; Rosario Notaro; Peter Browett; Jong Wook Lee; Mingjun Huang; Michael Geffner; Robert A Brodsky
Journal:  Blood       Date:  2021-11-18       Impact factor: 22.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.